Tenet Healthcare Corporation (THC)
NYSE: THC · Real-Time Price · USD
194.51
+7.60 (4.07%)
May 6, 2026, 4:00 PM EDT - Market closed
Tenet Healthcare Stock Forecast
Stock Price Forecast
The 20 analysts that cover Tenet Healthcare stock have a consensus rating of "Strong Buy" and an average price target of $238.75, which forecasts a 22.74% increase in the stock price over the next year. The lowest target is $200 and the highest is $288.
Price Target: $238.75 (+22.74%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Tenet Healthcare stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 6 | 7 | 7 | 7 | 7 |
| Buy | 10 | 10 | 11 | 11 | 11 | 12 |
| Hold | 3 | 3 | 3 | 3 | 3 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 18 | 19 | 21 | 21 | 21 | 21 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $257 → $238 | Buy | Maintains | $257 → $238 | +22.36% | May 5, 2026 |
| Baird | Baird | Hold Maintains $167 → $210 | Hold | Maintains | $167 → $210 | +7.96% | May 5, 2026 |
| Stephens & Co. | Stephens & Co. | Buy Maintains $275 → $260 | Buy | Maintains | $275 → $260 | +33.67% | May 4, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $277 → $236 | Buy | Maintains | $277 → $236 | +21.33% | May 1, 2026 |
| Guggenheim | Guggenheim | Strong Buy Maintains $283 → $252 | Strong Buy | Maintains | $283 → $252 | +29.56% | May 1, 2026 |
Financial Forecast
Revenue This Year
22.21B
from 21.31B
Increased by 4.22%
Revenue Next Year
22.63B
from 22.21B
Increased by 1.87%
EPS This Year
18.25
from 15.49
Increased by 17.79%
EPS Next Year
17.89
from 18.25
Decreased by -1.96%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 23.3B | 24.6B | |||
| Avg | 22.2B | 22.6B | |||
| Low | 21.3B | 21.2B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 9.2% | 10.5% | |||
| Avg | 4.2% | 1.9% | |||
| Low | -0.1% | -4.6% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 32.81 | 21.48 | |||
| Avg | 18.25 | 17.89 | |||
| Low | 11.49 | 15.08 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 111.8% | 17.7% | |||
| Avg | 17.8% | -2.0% | |||
| Low | -25.9% | -17.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.